Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (191-200 of 487) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical ImplicationsRyan A Denu, Justin T Moyers, Mohamed A Gouda, et al.
Nature Medicine|October 3, 2022
Accelerated approvals hit the target in precision oncologyVivek Subbiah, Lori J Wirth, Razelle Kurzrock, et al.
Journal of Hematology & Oncology|August 28, 2022
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional responseHanna E Persha, Shumei Kato, Pradip De, et al.
Cutis|June 25, 2019
Vandetanib photoinduced cutaneous toxicitiesHung Q Doan, Mimi I Hu, Jennifer Goldstein, et al.
ESMO Open|April 19, 2020
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapyPete M Anderson, Jacob Scott, Shireen Parsai, et al.
JCO Precision Oncology|August 11, 2020
Activity of Brigatinib in Crizotinib and Ceritinib-Resistant <i>ROS1-</i> Rearranged Non-Small-Cell Lung CancerAparna Hegde, David S Hong, Amini Behrang, et al.
Clinical Lung Cancer|November 26, 2024
Biomarker Landscape of Antibody Drug Conjugates (ADCs) and Bispecific Antibodies in Clinical Trials for Lung CancerMadhan Srinivasan Kumar, Sameer Deshmukh, Charmi Bhanushali, et al.
Trends in Cancer|February 27, 2020
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?Jacob J Adashek, Ishwaria M Subbiah, Ignacio Matos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Progresses Toward Precision Medicine in <i>RET</i>-altered Solid TumorsCarmen Belli, Santosh Anand, Justin F Gainor, et al.
ESMO Open|August 21, 2020
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitorsKartik Anand, Geetanjali Sahu, Ethan Burns, et al.
Pageof 49

Showing results (191-200 of 487) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical ImplicationsRyan A Denu, Justin T Moyers, Mohamed A Gouda, et al.
Nature Medicine|October 3, 2022
Accelerated approvals hit the target in precision oncologyVivek Subbiah, Lori J Wirth, Razelle Kurzrock, et al.
Journal of Hematology & Oncology|August 28, 2022
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional responseHanna E Persha, Shumei Kato, Pradip De, et al.
Cutis|June 25, 2019
Vandetanib photoinduced cutaneous toxicitiesHung Q Doan, Mimi I Hu, Jennifer Goldstein, et al.
ESMO Open|April 19, 2020
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapyPete M Anderson, Jacob Scott, Shireen Parsai, et al.
JCO Precision Oncology|August 11, 2020
Activity of Brigatinib in Crizotinib and Ceritinib-Resistant <i>ROS1-</i> Rearranged Non-Small-Cell Lung CancerAparna Hegde, David S Hong, Amini Behrang, et al.
Clinical Lung Cancer|November 26, 2024
Biomarker Landscape of Antibody Drug Conjugates (ADCs) and Bispecific Antibodies in Clinical Trials for Lung CancerMadhan Srinivasan Kumar, Sameer Deshmukh, Charmi Bhanushali, et al.
Trends in Cancer|February 27, 2020
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?Jacob J Adashek, Ishwaria M Subbiah, Ignacio Matos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Progresses Toward Precision Medicine in <i>RET</i>-altered Solid TumorsCarmen Belli, Santosh Anand, Justin F Gainor, et al.
ESMO Open|August 21, 2020
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitorsKartik Anand, Geetanjali Sahu, Ethan Burns, et al.
Pageof 49